Exane Derivatives’s Nu Skin NUS Stock Holding History

Exane Derivatives’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$216	Hold	5	–	–	﹤0.01%	667
2022 Q1	$239	Hold	5	–	–	﹤0.01%	943
2021 Q4	$254	Hold	5	–	–	﹤0.01%	822
2021 Q3	$202	Hold	5	–	–	﹤0.01%	1010
2021 Q2	$277	Hold	5	–	–	﹤0.01%	1001
2021 Q1	$264	Hold	5	–	–	﹤0.01%	848
2020 Q4	$273	Sell	5 -79	-94%	-$4.16K	﹤0.01%	780
2020 Q3	$4.21K	Hold	84	–	–	﹤0.01%	518
2020 Q2	$3.21K	Hold	84	–	–	﹤0.01%	476
2020 Q1	$1.83K	Hold	84	–	–	﹤0.01%	506
2019 Q4	$3.52K	Sell	84 -1,586	-95%	-$64.7K	﹤0.01%	458
2019 Q3	$71K	Hold	1,670	–	–	0.01%	347
2019 Q2	$82.3K	Buy	+1,670	New	+$84.9K	0.01%	349

Other funds holding NUS

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return

Exane Derivatives's NUS Position: Q2 2022 in Review

Exane Derivatives held its Nu Skin (NUS) position steady in Q2 2022 at 5 shares worth $216. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Exane Derivatives first reported a position in NUS in Q2 2019 and has held it in 13 quarters since. The position peaked at $82.3K in Q2 2019. 222 funds tracked by Wall St. Rank hold NUS as of Q2 2022.

Exane Derivatives held 5 shares of Nu Skin worth $216 as of Q2 2022.
Exane Derivatives left its Nu Skin share count unchanged in Q2 2022.
Nu Skin made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #667 holding.
Exane Derivatives first reported a position in Nu Skin in Q2 2019 and has held it in 13 quarters since.
Exane Derivatives's Nu Skin position peaked at $82.3K in Q2 2019.
222 funds tracked by Wall St. Rank held Nu Skin as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.